
Glimestar-PM 3 Tablet ER
Marketer
Mankind Pharma Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimestar-PM 3 Tablet ER
Diabetic patients may find relief with Glyconia ER 3mg, a dual-action medication designed to manage blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, resulting in lower blood sugar. Always follow your physician's instructions regarding dosage and frequency. Taking Glyconia ER 3mg with food minimizes stomach discomfort. If you miss a dose, take it immediately unless your next dose is imminent; in that case, skip the missed dose and resume your regular schedule. Never double the dose. An overdose can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or missed meals increases the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before initiating treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating women should seek medical advice before use. Kidney function tests will be performed prior to treatment. Limit alcohol consumption to reduce the likelihood of adverse effects.
Uses of Glimestar-PM 3 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimestar-PM 3 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimestar-PM 3 Tablet ER with a meal.
Common Side effects of Glimestar-PM 3 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimestar-PM 3 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Glimestar-PM 3 Tablet ER with a meal.
How Glimestar-PM 3 Tablet ER works:
Glimestar-PM 3 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimestar-PM 3 Tablet ER and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimestar-PM 3 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimestar-PM 3 Tablet likely poses an unacceptable risk during lactation. Available human data indicate potential transfer to breast milk, with consequent infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimestar-PM 3 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimestar-PM 3 Extended-Release tablets cautiously; dosage modification may be necessary. Consult a physician. Glimestar-PM 3 Extended-Release tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimestar-PM 3 Tablet ER :
Should you forget a dose of Glimestar-PM 3 Tablet ER, take it immediately if you remember. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimestar-PM 3 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
